🍎 Food Class I - Dangerous
potential for contamination with listeria monocytogenes
All Recalls
95,114 total recalls in our database
🍎 Food Class I - Dangerous
potential for contamination with listeria monocytogenes
🍎 Food Class I - Dangerous
potential for contamination with listeria monocytogenes
🍎 Food Class I - Dangerous
potential for contamination with listeria monocytogenes
🍎 Food Class I - Dangerous
Barbeque sauce product contains undeclared allergens (soy) contained in sub-ingredient
🍎 Food Class I - Dangerous
potential for contamination with listeria monocytogenes
🍎 Food Class I - Dangerous
Undeclared Milk. During the firm's reordering process of labels, they discovered that the label does not list milk in its ingredient or contain statement.
🍎 Food Class I - Dangerous
potential for contamination with listeria monocytogenes
🍎 Food Class I - Dangerous
potential for contamination with listeria monocytogenes
🍎 Food Class I - Dangerous
potential for contamination with listeria monocytogenes
🍎 Food Class I - Dangerous
Undeclared walnuts
🍎 Food Class I - Dangerous
Undeclared allergens (wheat) on label, incorrect label was placed on product
🍎 Food Class I - Dangerous
potential for contamination with listeria monocytogenes
🍎 Food Class I - Dangerous
potential for contamination with listeria monocytogenes
💊 Drugs Class I - Dangerous
CGMP deviations: presence of N-Nitroso Carvedilol Impurity-1 (NNC 1), above the FDA recommended acceptable intake limit.
💊 Drugs Class I - Dangerous
Superpotent; sodium benzoate preservative
Carvedilol Tablets, USP, 12.5 mg, Rx only, a)500 Tablets, NDC 68462-164-05; b) 100 Tablets, NDC 68462-164-01, Manufactured for Glenmark Pharmaceuticals, NJ.
Glenmark Pharmaceuticals Inc., USA
💊 Drugs Class I - Dangerous
CGMP Deviations:N-Nitroso Carvedilol I impurity (NNCI-I) were found to be failing per current FDA recommended limit.
Carvedilol Tablets, USP, 25 mg, Rx only, a)500 Tablets, NDC 68462-165-05; b) 100 Tablets, NDC 68462-165-01, Manufactured for Glenmark Pharmaceuticals, NJ.
Glenmark Pharmaceuticals Inc., USA
💊 Drugs Class I - Dangerous
CGMP Deviations:N-Nitroso Carvedilol I impurity (NNCI-I) were found to be failing per current FDA recommended limit.
💊 Drugs Class I - Dangerous
Failed Dissolution Specifications.
💊 Drugs Class I - Dangerous
Failed Stability Specifications - 12-month stability test result for one of the known peptides is below the specification limit